Ticker Details
Immunocore Holdings
IPO Date:	February 5, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.61B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.01 | 2.45%
Avg Daily Range (30 D):	$0.63 | 1.88%
Avg Daily Range (90 D):	$0.68 | 1.95%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	.44M
Avg Daily Volume (90 D):	.32M

Trade Size
Avg Trade Size (Sh.):	74
Avg Trade Size (Sh.) (30 D):	93
Avg Trade Size (Sh.) (90 D):	81

Institutional Trades
Total Institutional Trades:	1,878
Avg Institutional Trade:	$1.75M
Avg Institutional Trade (30 D):	$1.11M
Avg Institutional Trade (90 D):	$1.31M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.54M
Avg Closing Trade (30 D):	$.77M
Avg Closing Trade (90 D):	$1.23M
Avg Closing Volume:	35.18K

News

Jan 30, 2026 @ 12:00 PM Immunocore announces R&D leadership evolution Source: Not Specified

Nov 7, 2025 @ 1:00 PM Immunocore presents Phase 1 data for hepatitis B c... Source: Immunocore Holdings Plc

Oct 30, 2025 @ 3:15 PM Growth Picks: 3 Low-Cost Stocks That Could Double ... Source: Chris Markoch

Aug 7, 2025 @ 3:54 PM Immunocore (IMCR) Q2 Revenue Jumps 30% Source: Jesterai

Mar 10, 2025 @ 7:00 PM Immunocore presents initial multiple ascending dos... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.58	$	$-.2
Diluted EPS	$-.58	$	$-.2
Revenue	$379.59M	$103.69M	$97.96M
Gross Profit	$376.88M	$103.18M	$96.92M
Net Income / Loss	$-29.23M	$-.18M	$-10.3M
Operating Income / Loss	$-45.11M	$-7.17M	$-14.88M
Cost of Revenue	$2.71M	$.51M	$1.04M
Net Cash Flow	$-39.35M	$10.48M	$11.09M
PE Ratio